Records containing: Immune Checkpoint Inhibitor
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-17A Phase 2, Randomized, Open-Label, Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-04-08Troponin to Detect Major Cardiovasculaire Advserse Events on Immune: a Case Control Retrospective Study
-
CLINICAL_TRIALS study record update · 2026-03-18Induction Chemotherapy Combined With Low-dose Radiation Plus Cadonilimab in Loco-regionally Advanced Nasopharyngeal Carcinoma: a Multi-center, Open-label, Randomized Controlled Phase III Clinical Trial
-
CLINICAL_TRIALS study record update · 2026-01-30Efficacy of Postoperative Adjuvant PD-1 Inhibitors Guided by a Deep Learning Model: a Multicenter, Prospective Cohort Study
-
CLINICAL_TRIALS study record update · 2026-01-16Analysis of PD-L1, TMB, CTDNA in Immunotherapy Response Monitoring and Prediction in Advancer Lung Cancer Treatment.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-14Efficacy and Safety of Combining Intestinal Low Dose Radiotherapy Plus Tislelizumab and Chemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2025-12-05PRaG-1 Plus PRaG Therapy in Advanced Solid Tumors: A Prospective Clinical Trial (PRaG 10.0)
-
CLINICAL_TRIALS study record update · 2025-09-23Study on the Relationship Between Opioid Drugs and the Therapeutic Efficacy of Immunotherapy
-
CLINICAL_TRIALS study record update · 2025-09-22Adjuvant Radiotherapy Combined With Sintilimab Versus Transarterial Chemoembolization (TACE) for Hepatocellular Carcinoma With Narrow Margins and High-Risk Features Following Resection: A Multi-center Phase III Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-09-03An Open-label, Single-arm Study to Evaluate the Efficacy and Safety of Multimodal Radiotherapy in the Treatment of Renal Cell Carcinoma Progressed After Prior Immunotherapy
-
CLINICAL_TRIALS study record update · 2025-07-17A Phase II Prospective, Open-Label, Single-Arm Study Evaluating the Efficacy and Safety of Spatially Fractionated Radiotherapy Combined With Immunotherapy in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-07-14Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With Immune Checkpoint Inhibitor for Advanced Non-small Cell Lung Cancer.
-
CLINICAL_TRIALS study record update · 2025-07-10Liver Cancer and Immunotherapy : Clinical Relevance of LIquid BioPSY
-
CLINICAL_TRIALS study record update · 2024-08-21Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer
-
CLINICAL_TRIALS study record update · 2024-06-06Toripalimab Combined With FLOT Regimen in Locally Advanced Gastric cancer-a Prospective, Open, Multi-center, Phase Ⅱ Clinical Study
-
CLINICAL_TRIALS study record update · 2024-04-23A Prospective, Single-arm PhaseⅡTrial of Neoadjuvant/Adjuvant Pembrolizumab Plus Platinum-doublet Chemotherapy (Chemo) in IIa-IIIb NSCLC
-
CLINICAL_TRIALS study record update · 2024-02-14The Evaluation the Relationship Between LAG-3 Expression / Immune Checkpoint Protein Expression and Neoadjuvant Chemotherapy Plus Immune Checkpoint Inhibitor in Triple Negative Breast Cancer
-
CLINICAL_TRIALS study record update · 2024-02-08Exploratory Study on the Therapeutic Effect Prediction Model of Immune Checkpoint Inhibitors for Advanced Biliary Tract Cancer
-
CLINICAL_TRIALS study record update · 2024-01-23Safety and Efficacy of Bacterial Strain RX-af01 Combined With PD-1 Antibody in Patients With Refractory Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-01-23Adjuvant Tislelizumab With or Without Lenvatinib for Patients at High-risk of Hepatocellular Carcinoma Recurrence After Curative Resection or Ablation: a Multicentric, Prospective Study
-
CLINICAL_TRIALS study record update · 2023-12-13Efficacy of COVID-19 Booster-Dose Vaccine for Re-infection Precaution and Dynamics of Specific Serum Antibodies in the Management of Lung Cancer Patients With Systemic Anti-cancer Treatment
-
CLINICAL_TRIALS study record update · 2023-11-21A Phase II Study of Pembrolizumab Plus Platinum and Pemetrexed as First Line Therapy in Advanced Non-squamous Non-small Cell Lung Cancer Patients With EGFR Exon 21 Point Mutation and Programmed Cell Death Ligand 1 Expression
-
CLINICAL_TRIALS study record update · 2023-08-18A Prospective, Multicenter, Open-label, Phase II Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal Cancer
-
CLINICAL_TRIALS study record update · 2023-08-08PD-1 Antibody Sintilimab Combined With Modified FLOT Regimen in the Treatment of Metastatic Gastric Cancer: a Phase II Clinical Study
-
CLINICAL_TRIALS study record update · 2023-07-20Significance of Hepatic Biomarkers in the Evaluation of Response to Treatment and Prognosis in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors